Integrating Compassion Into the Heart of American Healthcare

Who we are

The American Alternative Care Policy Network (AACPN) is a national coalition advancing legislation, research, and public awareness to bring evidence-based alternative therapies into the heart of American healthcare. We are proud to support initiatives that reflect the lived realities of people historically excluded from safe, effective care.

Our membership includes organizations involved in medical research, healthcare delivery, veterans services, and patient advocacy for conditions where alternative treatment options may offer support.

Learn more about our members and membership options

Our mission

The AACPN exists to integrate safe, legal, and scientifically validated access to alternative care treatments for all Americans–especially veterans, trauma survivors, and those seeking holistic, evidence-based healing - into the core of America's healthcare system.

AACPN exists at the intersection of innovation and accountability. We work to modernize outdated health systems by advancing legislation that reflects what science, practitioners, and patients already know: care must evolve.

Our philosophy

Plant Medicine Access

Holistic Wellness Integration

Integrative Medicine Collaboration

News & Insights

DOJ order to expedite hearing process for marijuana reclassification

Read the full order here

AACPN Statement on DOJ Rescheduling of Marijuana to Schedule III

The American Alternative Care Policy Network (AACPN) today issued the following statement in response to the Department of Justice’s decision to reclassify marijuana as a Schedule III substance under the Controlled Substances Act: “The Department of Justice’s decision to reschedule marijuana from Schedule I to Schedule III marks a meaningful, if overdue, shift in federal policy. By recognizing accepted medical use, this action begins to correct a long-standing misalignment be

DOJ announces hearing process for reclassifying marijuana to schedule 3

Press release: Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls